Long-term consequences for the treatment of hypertensive diabetes type 2 patients with a fixed combination of an ace-inhibitor and non-dihydropyridine-calcium-channel-blocker in comparison to other combination therapies

被引：0
|
作者：
Maxion-Bergemann, S
Wittenberg, W
Bergemann, R
机构：
[1] Abbott GmbH & Co KG, Ludwigshafen, Germany
[2] Inst Med Outcome Res, Lorrach, Germany
来源：
VALUE IN HEALTH | 2002年 / 5卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)61442-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：546 / 547
页数：2
相关论文
共 17 条
  • [1] Combination therapy with an ACE-inhibitor (ACEI)/calcium channel blocker (CCB) for hypertensive patients non-responsive to ACE-inhibitor monotherapy: An efficacy and safety trial
    Chrysant, SG
    Bakris, GL
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 102A - 102A
  • [2] Effect of a Fixed Combination ACE Inhibitor and Calcium Channel Blocker (Dironorm) on Endothelial Function in Untreated Hypertensive Patients
    Raev, D.
    Ivanov, I.
    AMERICAN JOURNAL OF HYPERTENSION, 2009, 22 : 9 - 9
  • [3] Safety and efficacy of combination ACE inhibitor/calcium channel blocker therapy versus ACE inhibitor monotherapy in African American patients with hypertension and type 2 diabetes
    Flack, JM
    Bakris, GL
    Mc Gregor, J
    Purkayastha, D
    Gatlin, M
    Nwose, OM
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 180A - 181A
  • [4] Beneficial effect of the long-term treatment with the combination of an ACE inhibitor and a calcium channel blocker on renal injury in rats with 5/6 nephrectomy
    Flores, O
    Arévalo, M
    Gallego, B
    Hidalgo, F
    Vidal, S
    López-Novoa, JM
    EXPERIMENTAL NEPHROLOGY, 1998, 6 (01): : 39 - 49
  • [5] Effect of a Fixed Combination ACE Inhibitor and Calcium Channel Blocker (Dironorm) on Central Blood Pressure and Aortic Stiffness in Untreated Hypertensive Patients
    Raev, D.
    Staneva, A.
    AMERICAN JOURNAL OF HYPERTENSION, 2009, 22 : 9 - 9
  • [6] COMBINATION CALCIUM ANTAGONISTS AND ACE- INHIBITORS IN TREATMENT HYPERTENSIVE PATIENTS WITH CORONARY ARTERY DISEASE AND TYPE 2 DIABETES
    Nikoghosyan, K.
    Gurgenyan, S.
    Vatinian, S.
    JOURNAL OF HYPERTENSION, 2010, 28 : E296 - E297
  • [7] Comparison between calcium channel blocker with angiotensin converting enzyme inhibitor or angiotensin II type 1 receptor blocker combination on the development of new-onset diabetes in hypertensive Korean patients
    Kim, Yong Hoon
    Her, Ae-Young
    Rha, Seung-Woon
    Choi, Byoung Geol
    Choi, Se Yeon
    Byun, Jae Kyeong
    Kang, Dong Oh
    Jang, Won Young
    Kim, Woohyeun
    Baek, Ju Yeol
    Choi, Woong Gil
    Kang, Tae Soo
    Ahn, Jihun
    Park, Sang-Ho
    Park, Sung Hun
    Hong, Ji Yeon
    Park, Ji Young
    Lee, Min-Ho
    Choi, Cheol Ung
    Park, Chang Gyu
    Seo, Hong Seog
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2020, 19 (01) : 405 - 413
  • [8] Comparison between calcium channel blocker with angiotensin converting enzyme inhibitor or angiotensin II type 1 receptor blocker combination on the development of new-onset diabetes in hypertensive Korean patients
    Yong Hoon Kim
    Ae-Young Her
    Seung-Woon Rha
    Byoung Geol Choi
    Se Yeon Choi
    Jae Kyeong Byun
    Dong Oh Kang
    Won Young Jang
    Woohyeun Kim
    Ju Yeol Baek
    Woong Gil Choi
    Tae Soo Kang
    Jihun Ahn
    Sang-Ho Park
    Sung Hun Park
    Ji Yeon Hong
    Ji Young Park
    Min-Ho Lee
    Cheol Ung Choi
    Chang Gyu Park
    Hong Seog Seo
    Journal of Diabetes & Metabolic Disorders, 2020, 19 : 405 - 413
  • [9] Effect of combination therapy of angiotensin-converting enzyme inhibitor plus calcium channel blocker on urinary albumin excretion in hypertensive microalubuminuric patients with type II diabetes
    Shigihara, T
    Sato, A
    Hayashi, K
    Saruta, T
    HYPERTENSION RESEARCH, 2000, 23 (03) : 219 - 226
  • [10] Evaluating the long-term cost-effectiveness of fixed-ratio combination insulin degludec/liraglutide (IDegLira) versus other treatment regimens in the chinese type 2 diabetes patients
    Ran Wei
    Weihao Wang
    Xiusheng Huang
    Jingtao Qiao
    Jinghe Huang
    Chang Xing
    Qi Pan
    Lixin Guo
    Diabetology & Metabolic Syndrome, 15
12